Astellas, Vical's Lead CMV Vaccine Flunks Key Phase III Study
The drug did not meet its primary or secondary endpoints in the Phase 3 HELIOS clinical trial. Source: BioSpace
The drug did not meet its primary or secondary endpoints in the Phase 3 HELIOS clinical trial. Source: BioSpace
Life sciences professionals don't have to look far for opportunity in Genetown. Source: BioSpace
The combined company will be renamed upon closing and will be led by Vincent Milano, CEO of Idera, who will also serve as a member of the Board. Source: BioSpace
With the commercial launch of newly-approved Parkinson's disease treatment Gocovri, Bay Area drugmaker Adamas is growing. Source: BioSpace
Wall Street projects these three biotechs will grow the fastest over the next 12 months. Source: BioSpace
Shire will have its new CFO in March. Source: BioSpace
The survey of 51 oncologists suggests broad uptake of Imfinzi in advanced lung cancer patients who can't be treated with surgery. Source: BioSpace
This little-known hedge fund that has a focus on biotech and the life sciences beat out a couple of the heavy-hitters, David Einhorn and Bill Ackman. Source: BioSpace
Perlstein's approach with his start-up, Perlara, is radically different from how most start-ups operate. Source: BioSpace
The company will use the cash for working capital and general corporate purposes, including R&D activities. Source: BioSpace